
EMA greenlights two orphan drugs and two biosimilars
Two of six new meds to be approved in Europe are biosimilar medicines and have been backed by the European Medicines Agency (EMA) this...

Boehringer and Epizyme enter US$300m deal
According to BI, more than half of cancers can stem from functional errors in epigenetic modification, which diagnostically characterise the patient...

Investors pool €27m for new Proteomics tech
Developed at the University of Cambridge, Fluidic Analytics’ platform is designed to give insights into the way that proteins fold, aggregate and...

AI provides face read-out of genetic diseases
A self-learning algorithm created by US-Israelian company FDNA identified rare genetic syndromes with high accuracy following training on tens of...

Microbiome defines gut conditions
Studying over 1,700 individuals delivered differences in gut microbiome composition and function among patients with the inflammatory...

New target for lung fibrosis discovered
Seeking for the reason why myofibroblasts, which normally secrete collagen in response to inflammatory signals to repair tissue injury in the lungs,...

XyloCor Therapeutics bags US$17m in Series A financing
The Amsterdam-based company said it will primarily use the proceeds to advance its lead product XC001, licenced from Weill Cornell Medicine, to...